India Artificial Tears Market Research Report By Type (Polyethylene Glycol, Propylene Glycol, Cellulose, Glycerin, Others), By Delivery Mode (Eye Drops, Ointments, Sprays), By Application (Dry Eye Syndrome, Allergies, Infections, Others), and By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, Online Pharmacies) - Growth & Industry Forecast 2025 To 2035
Forecast Period
2025 - 2035
CAGR
6.55%
2024 Market Size
$ 218.95 Million
2035 Market Size
$ 440 Million
Healthcare● Updated February 6, 2026Report ID: MRFR/HC/51599-HCR|Pages: 200|Author: Rahul Gotadki
India Artificial Tears Market Summary
As per Market Research Future analysis, the India Artificial Tears Market size was estimated at 218.95 USD Million in 2024. The Artificial Tears market is projected to grow from 233.29 USD Million in 2025 to 440.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025 - 2035
Key Market Trends & Highlights
The India artificial tears market is experiencing robust growth driven by increasing awareness and technological advancements.
The market is witnessing a rising incidence of dry eye syndrome, which is propelling demand for artificial tears.
Technological advancements in formulations are enhancing product efficacy and consumer satisfaction.
There is a notable shift towards over-the-counter products, making them more accessible to consumers.
Key market drivers include increasing awareness of eye health and the aging population, which is amplifying eye care needs.
Market Size & Forecast
2024 Market Size
218.95 (USD Million)
2035 Market Size
440.0 (USD Million)
CAGR (2025 - 2035)
6.55%
Major Players
Allergan (US), Santen Pharmaceutical (JP), Bausch Health (CA), Novartis (CH), Johnson & Johnson (US), Alcon (CH), Otsuka Pharmaceutical (JP), Hyaluronic Acid (US)
Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry
India Artificial Tears Market Trends
The India Artificial Tears Market is currently experiencing notable growth, driven by an increasing prevalence of dry eye conditions among the population. Factors such as environmental changes, prolonged screen time, and lifestyle choices contribute to the rising incidence of this ailment. As awareness regarding eye health expands, consumers are seeking effective solutions to alleviate discomfort. This trend is further supported by advancements in formulation technologies, which enhance the efficacy and comfort of artificial tears. Consequently, manufacturers are focusing on developing innovative products that cater to diverse consumer needs, including preservative-free options and those with added therapeutic benefits.
Moreover, the regulatory landscape in India is evolving, with authorities emphasizing the importance of safety and efficacy in ophthalmic products. This shift encourages companies to invest in research and development, leading to the introduction of new formulations and delivery systems. The growing preference for over-the-counter products also indicates a shift in consumer behavior, as individuals increasingly opt for self-medication. Overall, the artificial tears market is poised for continued expansion, driven by a combination of consumer demand, technological advancements, and regulatory support.
Rising Incidence of Dry Eye Syndrome
The prevalence of dry eye syndrome is increasing, attributed to factors such as urbanization and lifestyle changes. This condition affects a significant portion of the population, leading to heightened demand for artificial tears as a remedy.
Technological Advancements in Formulations
Innovations in formulation technologies are enhancing the effectiveness of artificial tears. New products are being developed with improved viscosity and longer-lasting hydration, catering to the specific needs of consumers.
Shift Towards Over-the-Counter Products
There is a noticeable trend towards the use of over-the-counter artificial tears. Consumers are increasingly opting for self-treatment options, reflecting a growing awareness of eye health and the availability of effective solutions.
India Artificial Tears Market Drivers
Increasing Awareness of Eye Health
The growing awareness regarding eye health in India appears to be a significant driver for the artificial tears market. As more individuals recognize the importance of maintaining eye moisture and comfort, the demand for artificial tears is likely to rise. Educational campaigns and health initiatives by both governmental and non-governmental organizations have contributed to this awareness. Reports indicate that the artificial tears market in India is projected to grow at a CAGR of approximately 8% over the next few years. This trend suggests that consumers are increasingly seeking solutions for dry eyes, thereby expanding the market for artificial tears.
Aging Population and Eye Care Needs
India's demographic shift towards an aging population is likely to impact the artificial tears market positively. As individuals age, they often experience a higher prevalence of dry eye conditions due to various factors, including reduced tear production. The artificial tears market is expected to benefit from this demographic trend, as older adults are more likely to seek relief from dry eye symptoms. Current estimates suggest that by 2030, around 20% of India's population will be over 60 years old, which could significantly increase the demand for artificial tears. This demographic change indicates a growing market potential for eye care products.
Rising Urbanization and Lifestyle Changes
Urbanization in India is contributing to lifestyle changes that may lead to increased eye strain and dryness. Factors such as prolonged screen time, exposure to pollution, and air conditioning are becoming more prevalent in urban settings. These lifestyle changes are likely to drive the demand for artificial tears as individuals seek relief from discomfort caused by dry eyes. The artificial tears market is expected to see a notable increase in sales as urban dwellers become more aware of the need for eye care products. Market analysts suggest that this trend could lead to a growth rate of around 7% in the coming years.
Expansion of Retail and E-commerce Channels
The expansion of retail and e-commerce channels in India is facilitating easier access to artificial tears. With the rise of online shopping platforms, consumers can conveniently purchase eye care products from the comfort of their homes. This accessibility is likely to boost the artificial tears market, as more individuals are inclined to try these products. Additionally, brick-and-mortar pharmacies are increasingly stocking a wider range of artificial tears, catering to diverse consumer needs. The combination of retail growth and e-commerce is expected to enhance market penetration, potentially increasing sales by 10% in the next few years.
Government Initiatives and Healthcare Policies
Government initiatives aimed at improving healthcare access in India may positively influence the artificial tears market. Policies that promote eye health and subsidize eye care products can enhance affordability and availability for consumers. The government's focus on reducing the burden of eye-related ailments is likely to encourage the use of artificial tears among the population. Furthermore, collaborations between the government and healthcare providers to raise awareness about dry eye conditions could lead to increased consumption of artificial tears. This supportive environment may result in a projected market growth of approximately 9% over the next few years.
Market Segment Insights
By Type: Polyethylene Glycol (Largest) vs. Glycerin (Fastest-Growing)
In the India artificial tears market, the segment distribution reveals that Polyethylene Glycol holds the largest market share due to its superior viscosity and moisture-retaining properties, making it a preferred choice among consumers. Following closely are Propylene Glycol and Cellulose, which also contribute significantly to the market. Glycerin, while not leading, has gained traction for its effectiveness in treating dry eye conditions, reflecting a dynamic distribution across these segment values.
The growth trends in this segment are indicative of a rising demand for formulations that provide relief from dry eyes, driven by increasing screen time and environmental factors affecting eye health. Glycerin, showing the fastest growth, appeals to a younger demographic seeking effective and convenient solutions. Innovations in product formulations and an emphasis on quality ingredients will likely continue to drive segment growth.
Polyethylene Glycol (Dominant) vs. Glycerin (Emerging)
Polyethylene Glycol remains the dominant component in the India artificial tears market, prized for its effectiveness in providing long-lasting relief from dry eye symptoms. Its unique formulation enables enhanced moisture retention, aiding in user comfort, which is crucial for regular consumers. Conversely, Glycerin has emerged as a compelling alternative, particularly among younger consumers who value innovative and effective solutions for eye care. Though historically overshadowed by Polyethylene Glycol, Glycerin's emerging popularity can be attributed to its compatibility with various formulations and a growing awareness of its moisturizing capabilities. The evolving perception of eye health, driven by lifestyle changes, underscores the importance of both these compounds in shaping market dynamics.
By Delivery Mode: Eye Drops (Largest) vs. Ointments (Fastest-Growing)
In the India artificial tears market, eye drops hold the largest share, dominating the delivery mode segment due to their widespread acceptance and ease of use among consumers. Ointments and sprays, while present, occupy significantly smaller portions of the market. The convenience and familiarity associated with eye drops make them a preferred choice, leading to their substantial market presence.
Growth trends indicate that ointments are becoming the fastest-growing delivery mode, driven by an increase in the prevalence of eye-related conditions and a rising demand for long-lasting relief. Sprays are also witnessing rising interest, primarily among younger consumers seeking new alternatives. As awareness about eye health rises, these segments are poised for significant growth in the coming years.
Eye Drops: Dominant vs. Sprays: Emerging
Eye drops serve as the dominant delivery mode in the India artificial tears market, recognized for their effectiveness and user-friendly application. They are designed for quick absorption, providing immediate relief from dryness and irritation. Ointments, although slightly behind in market share, are emerging rapidly due to their therapeutic properties, offering prolonged relief and moisturizing effects. Sprays, while currently in an emerging position, are gaining traction for their innovative delivery method, appealing to consumers who prefer a non-invasive and convenient solution. The differentiation among these delivery modes reflects consumer preferences and highlights the diverse needs within the market, ensuring that various options are available for effective eye care.
By Application: Dry Eye Syndrome (Largest) vs. Allergies And Infections (Fastest-Growing)
In the India artificial tears market, Dry Eye Syndrome holds the largest share among the application segments, signifying its prevalence and the growing awareness of eye health issues. This segment captures the attention of consumers seeking relief from discomfort caused by dry conditions, digital strain, and environmental factors, contributing significantly to the overall market dynamics. In contrast, Allergies and Infections represent a rapidly growing segment, driven by increasing exposure to allergens and infections, particularly in urban areas where pollution and lifestyle factors exacerbate these conditions.
Growth trends in the India artificial tears market indicate a rising demand for effective solutions to address the symptoms of Dry Eye Syndrome, influenced by lifestyle changes and prolonged screen exposure. On the other hand, the Allergies and Infections segment is witnessing faster growth due to heightened awareness of eye health and increased marketing efforts by manufacturers. Innovative formulations and delivery methods are further propelling this segment, as consumers look for quick relief and convenience, making it a key area of focus for industry growth.
Dry Eye Syndrome (Dominant) vs. Allergies And Infections (Emerging)
Dry Eye Syndrome is the dominant application in the India artificial tears market, reflecting the significant number of individuals affected by this condition. This segment emphasizes the need for effective moisture retention and symptomatic relief solutions tailored to the lifestyle habits of consumers today. In contrast, the Allergies and Infections segment is emerging rapidly, shaped by increased urbanization and environmental challenges. Consumers are seeking solutions to combat irritation caused by allergens in their surroundings. The growth in this segment is largely driven by a greater awareness of eye health and the development of advanced artificial tear formulations that cater to specific user needs, making it a valuable focus for manufacturers aiming to capture a wider consumer base.
By Distribution Channel: Hospital Pharmacies (Largest) vs. Online Pharmacies (Fastest-Growing)
In the India artificial tears market, distribution channels are critical for ensuring product accessibility. Among these channels, hospital pharmacies hold the largest market share, attributed to the high volume of patients seeking treatment for various ocular conditions. Following closely are retail and drug stores, which serve as convenient points for patients to purchase these essential products. Online pharmacies, although currently a smaller segment, are rising in demand, providing a hassle-free purchasing option for consumers.
Looking at growth trends, online pharmacies are becoming the fastest-growing channel in this market. The increasing consumer preference for convenient shopping and the rise of digital health platforms are driving this trend. Moreover, hospital pharmacies continue to thrive due to their established relationships with healthcare providers and the trust they build with patients. As the importance of ocular health grows, the competition among these channels intensifies, indicating a dynamic market landscape ahead.
Hospital Pharmacies: Dominant vs. Online Pharmacies: Emerging
Hospital pharmacies play a dominant role in the India artificial tears market, offering a range of products recommended by healthcare professionals. Their established presence in the healthcare system enables patients to access treatments quickly, which is crucial for effective management of eye health issues. Furthermore, these pharmacies are often equipped to provide professional consultations, ensuring customers receive tailored recommendations. Conversely, online pharmacies are emerging as a significant player, driven by the convenience of e-commerce and the growing trend of telehealth. They offer wider product selections and competitive pricing, appealing to tech-savvy consumers. The shift toward online purchasing is facilitated by improved logistics and trust in digital payment systems, positioning online pharmacies as a formidable challenger in the market.
Get more detailed insights about India Artificial Tears MarketRequest Free Sample
Key Players and Competitive Insights
The artificial tears market in India is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Allergan (US), Santen Pharmaceutical (JP), and Bausch Health (CA) are actively pursuing strategies that enhance their market presence and operational efficiency. For instance, Allergan (US) has focused on expanding its product portfolio through innovative formulations that cater to diverse consumer needs, while Santen Pharmaceutical (JP) emphasizes its commitment to research and development, aiming to introduce cutting-edge solutions for dry eye syndrome. Bausch Health (CA) appears to be leveraging strategic partnerships to enhance distribution channels, thereby increasing accessibility to its products across various regions in India. Collectively, these strategies contribute to a dynamic competitive environment, where companies are not only vying for market share but also striving to meet evolving consumer expectations.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. This approach is particularly relevant in a moderately fragmented market where multiple players vie for dominance. The competitive structure is influenced by the presence of both multinational corporations and local manufacturers, each contributing to a diverse product offering. The collective influence of these key players fosters a competitive atmosphere that encourages innovation and responsiveness to market demands.
In October Johnson & Johnson (US) announced the launch of a new line of preservative-free artificial tears, aimed at addressing the growing consumer preference for safer, more effective eye care solutions. This strategic move is significant as it aligns with the increasing awareness of the potential side effects associated with preservatives in eye drops. By introducing this product line, Johnson & Johnson (US) not only enhances its competitive positioning but also responds to a critical consumer demand, potentially capturing a larger market share.
In September Alcon (CH) unveiled a digital platform designed to facilitate telehealth consultations for patients suffering from dry eye conditions. This initiative reflects a broader trend towards digitalization in healthcare, allowing for more accessible and convenient patient care. The strategic importance of this move lies in its potential to enhance patient engagement and streamline the treatment process, thereby positioning Alcon (CH) as a leader in innovative eye care solutions.
In August Santen Pharmaceutical (JP) entered into a strategic alliance with a local Indian firm to enhance its distribution network across the country. This partnership is indicative of a growing trend where foreign companies seek to leverage local expertise to navigate the complexities of the Indian market. The strategic importance of this alliance lies in its potential to improve market penetration and ensure that Santen's products reach a wider audience, thereby strengthening its competitive foothold in the region.
As of November the competitive trends in the artificial tears market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are playing a crucial role in shaping the current landscape, enabling companies to pool resources and expertise. Looking ahead, it is likely that competitive differentiation will evolve, with a pronounced shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This evolution suggests that companies that prioritize these aspects will be better positioned to thrive in an increasingly competitive market.
Key Companies in the India Artificial Tears Market include
Industry Developments
The India Artificial Tears Market has witnessed significant developments recently, particularly with major players like Allergan, Sun Pharmaceutical, Otsuka Pharmaceutical, and Cipla focusing on expanding their product offerings amid increasing demand for eye care solutions.
In October 2023, Dr. Reddy's Laboratories launched a new variant of artificial tears aimed at providing longer-lasting hydration, addressing the growing prevalence of dry eye syndrome in India. In previous years, Johnson and Johnson expanded its product line in May 2022, introducing preservative-free options to cater to a more sensitive consumer demographic.
Recent collaborations include Zydus Cadila and Alcon evaluating joint ventures for innovative eye care technologies. The market is experiencing a shift due to the rising incidence of lifestyle-related eye conditions and increasing awareness about eye health, contributing to market growth and valuation adaptations.
Mylan has been actively seeking partnerships to enhance its research capabilities in artificial tears as well. The regulatory landscape continues to evolve, with the Indian government emphasizing the importance of eye health, further underscoring the market's critical nature within the healthcare segment.
Future Outlook
India Artificial Tears Market Future Outlook
The Artificial Tears Market is projected to grow at a 6.55% CAGR from 2025 to 2035, driven by increasing prevalence of dry eye conditions and rising awareness of eye health.
New opportunities lie in:
Development of preservative-free formulations for sensitive users.
Expansion of e-commerce platforms for direct-to-consumer sales.
Partnerships with ophthalmology clinics for product endorsements.
By 2035, the market is expected to achieve substantial growth, reflecting evolving consumer needs and innovative product offerings.
Market Segmentation
India Artificial Tears Market Type Outlook
Polyethylene Glycol
Propylene Glycol
Cellulose
Glycerin
Others
India Artificial Tears Market Application Outlook
Dry Eye Syndrome
Allergies And Infections
Others
India Artificial Tears Market Delivery Mode Outlook
Eye Drops
Ointments
Sprays
India Artificial Tears Market Distribution Channel Outlook
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Online Pharmacies
Report Scope
MARKET SIZE 2024
218.95(USD Million)
MARKET SIZE 2025
233.29(USD Million)
MARKET SIZE 2035
440.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)
6.55% (2025 - 2035)
REPORT COVERAGE
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR
2024
Market Forecast Period
2025 - 2035
Historical Data
2019 - 2024
Market Forecast Units
USD Million
Key Companies Profiled
Allergan (US), Santen Pharmaceutical (JP), Bausch Health (CA), Novartis (CH), Johnson & Johnson (US), Alcon (CH), Otsuka Pharmaceutical (JP), Hyaluronic Acid (US)
Segments Covered
Type, Delivery Mode, Application, Distribution Channel
Key Market Opportunities
Growing demand for innovative formulations addressing dry eye syndrome in the artificial tears market.
Key Market Dynamics
Rising consumer awareness and demand for preservative-free artificial tears drive market growth in India.
Countries Covered
India
FAQs
What was the market valuation of the India artificial tears market in 2024?
The market valuation was $218.95 Million in 2024.
What is the projected market valuation for the India artificial tears market by 2035?
The projected valuation for 2035 is $440.0 Million.
What is the expected CAGR for the India artificial tears market during the forecast period 2025 - 2035?
The expected CAGR is 6.55% during the forecast period 2025 - 2035.
Which delivery mode segment had the highest valuation in 2024?
The Eye Drops segment had the highest valuation at $109.48 Million in 2024.
What are the key players in the India artificial tears market?
Key players include Allergan, Santen Pharmaceutical, Bausch Health, Novartis, Johnson & Johnson, Alcon, Otsuka Pharmaceutical, and Hyaluronic Acid.
Which application segment is projected to grow the most by 2035?
The Dry Eye Syndrome application segment is projected to grow the most, reaching $220.0 Million by 2035.
What was the valuation range for Glycerin in the type segment in 2024?
The valuation range for Glycerin in the type segment was $50.0 Million to $100.0 Million in 2024.
How does the valuation of Online Pharmacies compare to Retail Pharmacies in 2024?
In 2024, Online Pharmacies were valued at $68.95 Million, while Retail Pharmacies were valued at $70.0 Million.
What is the valuation range for the Others segment in the type category?
The Others segment in the type category had a valuation range of $73.95 Million to $150.0 Million.
Which distribution channel segment is expected to see significant growth by 2035?
The Retail Pharmacies distribution channel segment is expected to see significant growth, reaching $150.0 Million by 2035.
Author
Author
Rahul Gotadki
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
No country-specific reports available for this market.
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah MalgeriCo-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph AguayoSales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkampAccount and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria DoddProgram Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan ChoiSenior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile").
In general the report is well structured. Thanks very much for your efforts.”
Mark IrwinManagement Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob KooikerGroup Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif MorogluStrategy & Business Development Director
“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”
Guilherme Gomes MartinsProduct Management Director